| Literature DB >> 35168431 |
Francesco Godizzi1, Mario Caniatti1, Elisabetta Treggiari2, Giorgio Romanelli2, Ugo Bonfanti3, Gabriele Ghisleni4, Paola Roccabianca1.
Abstract
Papillary endothelial hyperplasia (PEH) is a rare soft tissue lesion arising from excessive reactive endothelial cell proliferation described in humans, dogs, and horses. PEH is considered a diagnostic challenge in humans, in which it is frequently misdiagnosed as angiosarcoma. We describe here PEH that developed at injection sites in 2 cats that were initially misdiagnosed as feline injection-site sarcoma by cytology and as subcutaneous angiosarcoma by histopathology. Morphologic features included sharp demarcation from surrounding tissues, and a layered microscopic architecture with an outer fibrous capsule from which emerged fibrovascular stalks covered by a monolayer of factor VIII-related antigen and CD31-positive flat-to-plump endothelial cells. Both lesions had a cystic core containing abundant erythrocytes and fibrin. PEH lesions did not recur in either case. Immunohistochemistry for α-smooth muscle actin and desmin demonstrated that the capsule was devoid of smooth muscle cells, excluding an intravascular origin. PEH in these cats was hypothesized to have developed extravascularly following trauma related to injection. We wish to provide awareness of PEH in domestic cats and of the risk of misdiagnoses leading to overtreatment.Entities:
Keywords: angiosarcoma; endothelial cells; feline; feline injection-site sarcoma; hyperplasia; papillary endothelial hyperplasia
Mesh:
Year: 2022 PMID: 35168431 PMCID: PMC9254058 DOI: 10.1177/10406387221079845
Source DB: PubMed Journal: J Vet Diagn Invest ISSN: 1040-6387 Impact factor: 1.569